Literature DB >> 17692378

Clinical features of chinese patients with Behçet's disease.

Peizeng Yang1, Wang Fang, Qianli Meng, Yalin Ren, Lin Xing, Aize Kijlstra.   

Abstract

PURPOSE: To characterize the clinical features of Behçet's disease in Chinese patients.
DESIGN: Retrospective noncomparative case series. PARTICIPANTS: Seven hundred seventy-five eyes of 437 patients with Behçet's disease initially examined from August, 1995, through June, 2006.
METHODS: The history, demographic parameters, and clinical findings of all consecutive Behçet's patients referred to the uveitis study center of Sun Yat-sen University were reviewed. Laser flare-cell photometry (LFCM), fundus fluorescein angiography (FFA), optical coherence tomography (OCT), ultrasound biomicroscopy (UBM), and B-scan ultrasonography were performed in certain cases. Most patients were treated by immunosuppressive agents combined with oral corticosteroids. MAIN OUTCOME MEASURES: Patient demographics, clinical presentation, and auxiliary examination findings.
RESULTS: Four hundred thirty-seven patients were diagnosed with Behçet's disease. There were 319 male and 118 female patients. Panuveitis was the most common type of uveitis in both genders, although anterior uveitis was seen more frequently in females. Retinal vasculitis, vitreitis, and retinitis were the most common ocular manifestations in these patients. Cataract and macular edema were the most common complications. Oral aphthae were the most frequent extraocular manifestation, followed by dermatologic lesions, and genital ulcers. The results of FFA, OCT, B-scan ultrasonography, LFCM, and UBM generally were in accordance with or comparable with clinical observations. At the final visit, uveitis was well controlled in 86.2% of patients. However, 20.4% of eyes became legally blind despite aggressive treatment. Kaplan-Meier analysis estimated the risk of losing useful vision (0.05) at 5 and 10 years for males and females as 29% versus 6% and 65% versus 33%, respectively.
CONCLUSIONS: Behçet's disease in Chinese patients mainly manifests as nongranulomatous uveitis frequently associated with oral aphthae and dermatologic lesions. Fundus fluorescein angiography, B-scan ultrasonography, LFCM, UBM, and OCT may provide much information about pathophysiologic hallmarks of Behçet's disease. A combination of corticosteroids with other immunosuppressive agents is effective for most patients with Behçet's disease. Males had a more severe course and were at higher risk for losing vision than females.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692378     DOI: 10.1016/j.ophtha.2007.04.056

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  61 in total

1.  Gender influence on ocular manifestations and their outcome in Behcet's Disease. A long-term follow-up of up to 20 years.

Authors:  Fereydoun Davatchi; Farhad Shahram; Hormoz Shams; Abdolhadi Nadji; Cheyda Chams-Davatchi; Massoomeh Akhlaghi; Seyedeh Tahereh Faezi; Farima Ashofteh; Bahar Sadeghi-Abdollahi
Journal:  Clin Rheumatol       Date:  2010-09-22       Impact factor: 2.980

2.  Ocular manifestations of Behçet's disease in Jordanian patients.

Authors:  Mohammed A Abu-Ameerh; Sawsan F Mohammed; Mona T Mohammad; Osama H Ababneh; Muawyah D Al-Bdour
Journal:  Saudi J Ophthalmol       Date:  2013-07-01

3.  Alterations of aqueous flare and cells detected by laser flare-cell photometry in patients with Behcet's disease.

Authors:  Peizeng Yang; Wang Fang; Xiangkun Huang; Hongyan Zhou; Li Wang; Bo Jiang
Journal:  Int Ophthalmol       Date:  2008-05-15       Impact factor: 2.031

4.  Pattern of uveitis in Behçet's disease in a referral center in Tunisia, North Africa.

Authors:  Moncef Khairallah; Sonia Attia; Salim Ben Yahia; Salah Jenzeri; Rim Ghrissi; Bechir Jelliti; Sonia Zaouali; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2008-03-26       Impact factor: 2.031

Review 5.  Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility.

Authors:  Andrea Latini; Cinzia Ciccacci; Giuseppe Novelli; Paola Borgiani
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

6.  Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet's disease.

Authors:  Min Sun; Peizeng Yang; Yan Yang; Jian Ye
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

7.  Predisposition to Behçet's disease and VKH syndrome by genetic variants of miR-182.

Authors:  Hongsong Yu; Yunjia Liu; Lin Bai; Aize Kijlstra; Peizeng Yang
Journal:  J Mol Med (Berl)       Date:  2014-05-08       Impact factor: 4.599

8.  Behçet's Uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

9.  Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A.

Authors:  Wei Chi; Peizeng Yang; Xuefei Zhu; Yuqin Wang; Lina Chen; Xiangkun Huang; Xiaoli Liu
Journal:  Mol Vis       Date:  2010-05-19       Impact factor: 2.367

10.  Lack of association of two polymorphisms of IRF5 with Behcet's disease.

Authors:  Haijun Li; Peizeng Yang; Zhengxuan Jiang; Shengping Hou; Lin Xie
Journal:  Mol Vis       Date:  2009-10-07       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.